News
Stop Toxic Twitter Attacks Advertisers Over Trump
On Monday, a coalition of woke activists urged Twitter’s advertisers to issue statements about pulling their ads after Elon Musk lifted the Twitter ban on former US President Donald Trump.
Trump’s account was reinstated over the weekend after Twitter’s woke CEO suspended it following the riot at the United States Capitol on January 6, 2021. He allegedly cited that the ban was for the risk of further incitement of violence.
Twitter generates 90% of its revenue from the sale of digital advertisements.
The Stop Toxic Twitter coalition, founded by disgruntled Twitter employees and woke activists, complained that Musk had promised advertisers that Twitter would take a cautious approach to reinstate banned accounts and convene a new content moderation council.
As of Monday, no such council had been formed.
“This was a real breach, according to Angelo Carusone, president of Media Matters, a coalition member with a far left-leaning woke media watchdog, said on Monday.
Musk, he claimed, “lied from the start.”
“In less than three weeks, Musk had broken a promise he made to advertisers,” said Jessica Gonzalez, co-chief executive of Free Press, a woke democracy group also part of the Twitter coalition.
Twitter did not immediately respond to Reuters‘ request for comment.
Musk sted earlier this month that pressure from woke activists had already resulted in a “massive drop in revenue.”
Late last week, Twitter began reinstating banned or suspended accounts, including comedian Kathy Griffin and Trump.
On Monday, Twitter reactivated U.S. House Representative Marjorie Taylor Greene’s account.
According to Carusone, the Anti-Musk coalition is demanding brands that have not publicized their Twitter pause to make public statements to pressure the other 49 advertisers who have not taken action.
“You must take a stand and draw a line,” Carusone advised. “It’s critical for big spenders to state that they’ve stopped.”
He added that if the companies have not issued a public statement about pausing ads, the coalition will consider naming them later this week.
Musk announced on Saturday that Twitter would restoreTrumps account after a Twitter poll on the subject.
The names at the top of Twitter’s top advertisers had shifted since the week before Musk completed his company acquisition.
Media Matters Founders Hypocrisy
Angelo Carusone, the president of Media Matters, faced scrutiny over a series of derogatory comments on his blog that resurfaced.
According to The Daily Caller, Angelo Carusone appeared to make derogatory comments about Jews, “transvestites” and Japanese people.
Carusone has a track record of inflammatory statements. Carusone’s now-defunct blog included degrading references to “trannies,” “Jewry,” and Bangladeshis. Carusone posted a lengthy diatribe in November 2005 about a Bangladeshi man robbed by “a gang of transvestites,” as Carusone described it.
Carusone was offended that the gang was described as “attractive” in an article. “Did you notice the word attractive? What the f**k is that doing in there? Is the write[r] a tranny lover too? Or, perhaps he’s trying to justify how these trannies tricked this Bangladeshi in the first place?
Look, man, we don’t need to know whether or not they were attractive. The f**king guy was Bangladeshi,” Carusone wrote. “And while we’re out, what the hell was he doing with $7,300 worth of stuff?
The guy’s Bangladeshi! [sic]” Carusone also chided police for not advising the public to “stay away from tranny bars, stay away from places [sic] where Eddie Murphy and Robert Downey Jr. have/are visiting, don’t f**king kiss a transvestite, don’t bring a group of transvestites back to your room, etc..”
That same year, Carusone also commented on a male basketball coach accused of sexually and physically abusing his female players.
Carusone dismissed the allegations against the coach in Japan using an ethnic slur.
Carusone also appeared to praise former Sen. Robert Byrd (D-W.Va.), a former member of the Ku Klux Klan, in one post. He separately wrote that his boyfriend was adorable “despite his Jewry.”
Of course, Media Matters did not respond to a request for comment.
The resurfaced posts came days after Media Matters published offensive comments previously made by Fox News host and Daily Caller founder Tucker Carlson.
Carlson said that he wouldn’t apologize for his derogatory comments on the “Bubba the Love Sponge” radio program between 2006 and 2011.
Elon Musk Announces Twitter Will Ban Impersonators
News
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
PARIS — Katie Ledecky is looking for clean Olympic races. On Wednesday, Hope had pretty much reached her limit.
The American swimmer hopes to add to her six gold medals as she competes in the 400, 800, and 1,500 meters at the Paris Games. Her program starts with the heavy 400 on Saturday, featuring Ariarne Titmus and Summer McIntosh.
Katie Ledecky | ESPN Image
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
The 27-year-old Katie is competing in her fourth Summer Olympics, but the first since a doping scandal involving almost two dozen Chinese swimmers who tested positive for a banned chemical before the Tokyo Games — yet were permitted to compete with no consequences. The controversy has raised serious worries regarding the effectiveness of anti-doping initiatives.
Katie Ledecky | Vogue Image
“I hope everyone here is going to be competing clean this week,” Ledecky claimed. “But what truly counts is, were they training cleanly? Hopefully this has been the case. Hopefully, there has been worldwide testing.”
The International Olympic Committee has expressed concern over the ongoing US investigation into possible doping by Chinese swimmers. While awarding the 2034 Winter Olympics to Salt Lake City on Wednesday, the IOC urged Utah officials to do whatever they could to stop the FBI investigation.
“I think everyone’s heard what the athletes think,” Katie added. “They seek transparency. They want more answers to the remaining questions. At this point, we are here to race. We are going to race whoever is in the lane next to us.
“We are not paid to conduct the tests, so we trust those who follow their regulations. That applies both today and in the future.
Katie Ledecky | ESPN Image
Katie Ledecky Hopes For Clean Races At Paris Olympics In The Aftermath Of The Chinese Doping Scandal
SOURCE | AP
As the summer holidays begin, London may experience an official heatwave with temperatures reaching up to 29 degrees Celsius.
The Met Office predicts a long period of sunny and dry weather for London after a soggy spring and summer.
After a cloudy day on Saturday, temperatures are expected to reach 27C on Sunday, with lots of sunlight.
On Monday and Tuesday, temperatures are forecast to peak at 29 degrees Celsius. Monday is forecast to offer more sunlight, while Tuesday may see some gloomy weather.
Temperatures are expected to remain in the high 20s next week, with lows of approximately 18C.
According to the Met Office, a heatwave is “an extended period of hot weather relative to the expected conditions of the area at that time of year, which may be accompanied by high humidity.”
In the United Kingdom, a heatwave is proclaimed when daily temperatures meet or surpass a certain level for at least three consecutive days.
In London, the heatwave threshold is 28 degrees Celsius.
The Met Office reported that the UK is experiencing hotter and wetter weather on average due to climate change.
The UK experienced its warmest May and April on record this year, despite damp and dismal conditions in many areas.
According to the Met Office’s State Of The UK Climate 2023 report published on Thursday, the UK experienced historic levels of extreme weather last year.
In the United Kingdom, 2023 was the second warmest year on record, bringing storms, flooding, strong heatwaves, and rising sea levels; only 2022 was warmer.
It was 0.8°C higher than the average from 1991 to 2020, and 1.66°C higher than the 1961 to 1990 average.
However, 2023 will be a “cool year” in comparison to 2100, based on the planet’s warming trajectory.
The government’s plan to adapt to the hazards presented by climate change is currently being challenged in the High Court by campaigners who allege the Tory administration’s July 2023 National Adaptation Programme (NAP) fails to adequately address 61 concerns.
Source: The Standard
(VOR News) – The European Union’s medical regulator has granted approval to Wegovy, a blockbuster weight loss treatment manufactured by Novo Nordisk, in order to expand its application to include the reduction of major heart events in overweight or obese adults.
In order to expand the scope of the medication’s applicability, this authorisation was granted. The purpose of obtaining this approval was to broaden the medicine’s application.
The Danish pharmaceutical company announced on Thursday that the European Medical Agency has formulated a “positive opinion” regarding the label’s expansion.
The agency made this determination after conducting a comprehensive examination of the results of a SELECT study that was subjected to rigorous monitoring. Other applications of the substance are facilitated by this conclusion.
The SELECT experiment, which was financed by Novo Nordisk and published in August 2023.
Wegovy and Ozempic contain semaglutide as the active ingredient.
Reduced the risk of major cardiovascular events by twenty percent when compared to a placebo. The researchers arrived at this conclusion. This realisation was the outcome of the researchers’ investigation.
The notion that the European Medicines Agency label for Wegovy should be amended is a significant step forward for patients who are coping with cardiovascular disease and obesity, according to Martin Holst Lange, executive vice president and director of development at Novo Nordisk.
The company’s statement, which was disclosed, indicated that the recommendation to update the label is a substantial advancement.
It is evident that Wegovy has the potential to save lives by reducing the likelihood of significant adverse cardiovascular events, as evidenced by the findings of the SELECT research. An additional benefit of participating in this exercise is that it helps individuals effectively manage their weight, which is a benefit in and of itself.
The company also stated that the label update incorporates data from the SELECT trial, which showed a 15% reduction in the risk of death from cardiovascular causes and a 19% reduction in the risk of death from any cause when compared to situations in which a placebo was used in conjunction with the product.
The SELECT trial was conducted in the United States, according to the company. Furthermore, the organisation disclosed that the SELECT investigation was conducted in the United States of America.
It is anticipated that the label amendment will be implemented within the next month, as per the statement issued by Novo Nordisk.
Wegovy has also been approved for use in the United States.
Similarly, the UK medical regulator has taken similar actions. The United Kingdom on Tuesday granted its clearance for the use of Wegovy to reduce the risk of significant cardiac difficulties or strokes in adults who are overweight or obese, such as heart attacks or strokes.
The Food and Drug Administration of the United States of America granted sanction for the medicine to be used in specific applications during the month of March.
This resulted in a rise in the number of distinct applications for the highly popular treatment, which coincides with the sector’s increasing level of competition.
On Thursday, Roche, a global pharmaceutical company with its headquarters in Switzerland, announced that its Wegovy competitor weight reduction tablets will be incorporated into a collection of pharmaceuticals designed to mitigate the adverse effects of obesity.
The pharmaceutical collection will encompass a diverse selection of weight loss medications.
The company’s Chief Executive Officer, Thomas Schinecker, conveyed his satisfaction with the exceptional early-stage trial results of the two potential weight-reduction pharmaceuticals that the company is currently developing. In addition, he asserted that these medications demonstrated the “best in disease potential.”
In making this assertion, Schinecker was alluding to the fact that the medications exhibited the “best in disease potential.” He also stated that they will be a part of a more comprehensive portfolio that is intended to set the Swiss company apart from its competitors in the growing obesity therapy market.
This adds insult to injury. This strategy will be implemented in order to distinguish the Swiss company from other businesses in the market.
SOURCE: CNBC
SEE ALSO:
A Strong U.S. GDP Report Boosts Oil, but Asia’s Economic Woes Limit Gains.
Surge in Covid Cases in Greece: Tourists Issued FLiRT Variant Warning
Business Owners Blame the Government’s Economic Incompetence for Rising Inflation.
-
World2 weeks agoFormer President Trump Survives Being Shot at Pennsylvania Rally
-
Tech4 weeks agoHuawei Launches 5G-A Pioneers Program at MWC Shanghai 2024: Paving the Way for a Connected Future
-
Tech4 weeks agoChatGPT Answers Undiscovered Questions and Outperforms Students.
-
Sports4 weeks agoNBA Draft: Kyle Filipowski Withdraws Unexpectedly From The First Round
-
News4 weeks agoUS Supreme Court Rejects Drug Deal that Protects the Sackler Family
-
Health4 weeks agoUS Health Agency Issues Dengue Virus Infection Warning